0

Perlapine

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP1977113
CAS1977-11-3
Structure
Molecular Weight291.39
InChI KeySDBHDSZKNVDKNU-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: 10 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditionsroom temp
1

Effects of Clozapine, Thioridazine, Perlapine and Haloperidol on the Metabolism of the Biogenic Amines in the Brain of the Rat

H R Bürki, W Ruch, H Asper

Psychopharmacologia. 1975;41(1):27-33.

PMID: 235767

1

Olanzapine: A Potent Agonist at the hM4D(Gi) DREADD Amenable to Clinical Translation of Chemogenetics

Mikail Weston, Teresa Kaserer, Angela Wu, Alexandre Mouravlev, Jenna C Carpenter, Albert Snowball, Samuel Knauss, Melanie von Schimmelmann, Matthew J During, Gabriele Lignani, Stephanie Schorge, Deborah Young, etc.

Sci Adv. 2019 Apr 17;5(4):eaaw1567.

PMID: 31001591

1

Perlapine and Dopamine Metabolism: Prediction of Antipsychotic Efficacy

S Wilk, M Stanley

Eur J Pharmacol. 1977 Jan 7;41(1):65-72.

PMID: 12986

1

Perlapine: Relationship Between Stimulation of Prolactin Secretion and Antipsychotic Activity

H Y Meltzer, R G Fessler, V S Fang

Psychopharmacology (Berl). 1977 Oct 20;54(2):183-6.

PMID: 412213

1

The First Structure-Activity Relationship Studies for Designer Receptors Exclusively Activated by Designer Drugs

Xin Chen, Hyunah Choo, Xi-Ping Huang, Xiaobao Yang, Orrin Stone, Bryan L Roth, Jian Jin

ACS Chem Neurosci. 2015 Mar 18;6(3):476-84.

PMID: 25587888

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode